Investigational drug improves stool consistency in IBS-D

An investigational, bimodal release ondansetron tablet improved stool consistency in patients with diarrhea-predominant irritable bowel syndrome, according to study results.“Immediate release ondansetron has been evaluated in several small studies at doses from 4 mg daily to 16 mg daily, with favorable results, and no evidence of ischemic colitis or other significant side effects have been observed,” Terry F. Plasse, MD, of RedHill Biopharma and colleagues wrote. “RHB-102 is an investigational bimodal release formulation of ondansetron.”Researchers recruited 127Read More

Share on facebook
Share on twitter
Share on linkedin